During the past decade, NW FL Clinical Research Group LLC conducted 29 clinical trials. In the 10-year time frame, 29 clinical trials started and 16 clinical trials were completed, i.e. on average, 55.2% percent of trials that started reached the finish line to date. In the past 5 years, 13 clinical trials started and 8 clinical trials were completed. i.e. 61.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "NW FL Clinical Research Group LLC" #1 sponsor was "Allergan" with 6 trials, followed by "Sarepta Therapeutics, Inc." with 6 trials sponsored, "Zogenix International Limited, Inc., a subsidiary of Zogenix, Inc." with 3 trials sponsored, "Eisai Inc." with 2 trials sponsored and "Emalex Biosciences Inc." with 2 trials sponsored. Other sponsors include 14 different institutions and companies that sponsored additional 19 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "NW FL Clinical Research Group LLC" #1 collaborator was "Covance" with 1 trials as a collaborator, "Sunovion" with 1 trials as a collaborator, "Syneos Health" with 1 trials as a collaborator and "Zogenix International Limited, Inc., a subsidiary of Zogenix, Inc." with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "NW FL Clinical Research Group LLC" are "Epilepsy" (7 trials), "Dravet Syndrome" (5 trials), "Cerebral Palsy" (4 trials), "Muscle Spasticity" (4 trials) and "Pediatrics" (4 trials). Many other conditions were trialed in "NW FL Clinical Research Group LLC" in a lesser frequency.

Most popular intervention types in "NW FL Clinical Research Group LLC" are "Drug" (35 trials), "Biological" (7 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (13 trials), "SRP-5051" (3 trials), "ZX008 (Fenfluramine Hydrochloride)" (3 trials), "Botulinum Toxin Type A" (2 trials) and "Ecopipam" (2 trials). Other intervention names were less common.

The vast majority of trials in "NW FL Clinical Research Group LLC" are 31 trials for "All" genders and 7 trials for "Male" genders.

Currently, there are NaN active trials in "NW FL Clinical Research Group LLC". undefined are not yet recruiting, 10 are recruiting, 4 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 19 completed trials in NW FL Clinical Research Group LLC, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in NW FL Clinical Research Group LLC, 5 "Phase 1" clinical trials were conducted, 11 "Phase 2" clinical trials and 22 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 0 trials that are defined as “Not Applicable".